A COMPARATIVE STUDY OF CT AND MRI IN

NEUROIMAGING INVOLVES INVESTIGATING THE

STRENGTHS AND LIMITATIONS OF BOTH IMAGING

MODALITIES IN DIAGNOSING AND MONITORING

VARIOUS NEUROLOGICAL CONDITIONS.

TIMES INSTITUTE

MULTAN, PAKISTAN

By (14 font size)

STUDENT NAME (BLOCK LETTERS, 14 font size, Align center)

Registration Number (14 font size, Align center)

Master of Science/ Master of Philosophy

in

Subject (14 font size, Align center)

NAME OF DEPARTMENT (Block Letters, font size 16, ARIAL Bold and Align Center)

NAME OF FACULTY (Block Letters, font size 16, ARIAL Bold and Align Center)

TIMES INSTITUTE, MULTAN (Block Letters, font size 16, ARIAL Bold and Align Center)

PAKISTAN (Block Letters, font size 16, ARIAL Bold and Align Center)

2023 (Font size 16, ARIAL Bold and Align Center)

A COMPARATIVE STUDY OF CT AND MRI IN NEUROIMAGING INVOLVES INVESTIGATING THE STRENGTHS AND LIMITATIONS OF BOTH IMAGING MODALITIES IN DIAGNOSING AND MONITORING VARIOUS NEUROLOGICAL CONDITIONS.

TIMES INSTITUTE

MULTAN, PAKISTAN

By (14 font size)

STUDENT NAME (BLOCK LETTERS, 14 font size, Align center)

Registration Number (14 font size, Align center)

Abstract

The study aims to determine and compare the diagnostic accuracies of Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) in the neuroimaging of various neurological conditions. Employing a comparative cross-sectional design, this research will be conducted at a tertiary care hospital equipped with advanced imaging facilities. Over six months, data will be collected from medical records of 200 patients who have undergone both CT and MRI scans. The sampling will be purposive, ensuring the inclusion of diverse neurological conditions. Data analysis will involve chi-square tests for categorical data and t-tests or ANOVA for continuous data, aimed at highlighting the relative strengths and limitations of each modality in different neurological contexts. Ethical considerations will be meticulously observed, with approval from the Institutional Review Board and informed consent obtained from all participants. This study expects to provide evidence-based insights that could guide clinical decisions on the appropriate use of CT and MRI in neurology.

INTRODUCTION

Neurological pathologies exert a profound influence on the nervous system, precipitating an array of symptomatology emanating from structural, biochemical, or electrophysiological aberrations within the brain, spinal cord, or peripheral nerve architecture. These disorders present formidable challenges within the medical ecosystem due to the intricate interconnections of the nervous system, rendering their diagnosis, management, and therapeutic interventions some of the most arduous tasks within medical practice. The complexity of diagnostic difficulties in neurology has been reduced by the progressive development and use of sophisticated technology methods that improve the provision of immediate neurological treatment. A comprehensive analysis of medical literature and patient data indicates that there are around 600 distinct illnesses that may affect the neurological system. The conditions included in this list are dementia, epilepsy, cerebrovascular diseases, Alzheimer's disease, stroke, Parkinson's disease, multiple sclerosis, brain tumors, neuro-infections, brain trauma, and autism (Borsook, 2012).

Neurological disorders have a widespread impact on communities worldwide, regardless of factors such as age, gender, level of education, or socioeconomic situation. Brain neoplasms are very fatal tumors, distinguished by their elevated death rates and often resistant treatment (Feigin et al., 2020). Approximately 1,520 instances of brain cancer are identified each year in the United States, impacting more than 100,000 persons. During the last ten years, the survival percentage for individuals diagnosed with brain cancer has consistently stayed at about 75%. Simultaneously, progress in oncological treatments has resulted in a rise in cases of brain metastasis and enhancements in survival rates, therefore stimulating the creation of more precise diagnostic imaging techniques (Ilic & Ilic, 2023).

The emergence of advanced diagnostic imaging techniques, such as CT, Nuclear Medicine (NM), and MRI, has played a crucial role in using three-dimensional anatomical reconstructions of the human body. Diagnosing malignancies is crucial in assessing neurological illnesses, as it helps identify and define suitable treatment options and prognostic evaluations. MRI is often used for the evaluation of

cerebrovascular injury and the exclusion of other prevalent causes of neurological dysfunction. In addition, MRI of the brain enhances the process of making preliminary diagnoses that are particular to the anteroposterior shape. Advancements in MRI technology have significantly broadened our comprehension of diverse neurobiological changes, possibly stimulating the emergence of innovative neuroimaging methodologies (Aljahdali et al., 2024; Hussain et al., 2022).

In general, MRI is more efficacious than CT owing to its increased resolution of soft tissues, improved contrast capabilities, decreased presence of bone aberrations and volume-related concerns, as well as its ability to provide direct multi-planar imaging. MRI can identify even tiny metastases as it is being scanned (Florkow et al., 2022). On the other hand, CT is the preferred modality for diagnosing acute stroke due to its superior effectiveness and practicality, which includes its heightened sensitivity to Intracranial Hemorrhage (ICH). The adoption of these sophisticated imaging methods has been consistently reviewed in several epidemiological investigations. Prior studies mostly focused on the clinical occurrence of stroke, myocardial infarction, or death during the duration of the study, resulting in valuable insights into the advancement of diseases, illness understanding, and the intricacies of disease mechanisms (De Luca et al., 2024).

Previous studies have highlighted the progress made in diagnostic imaging methods, including CT and MRI, for neurological conditions. However, these studies have not provided a complete assessment of the diagnostic accuracy of these modalities. There is an urgent need to evaluate the diagnostic precision of CT and MRI in assessing neurological illnesses and to do a comparison study to find whether one modality has more diagnostic effectiveness than the other. Furthermore, a comprehensive analysis of the correlations between patient demographics, including gender and patient type, might provide valuable insights into the potential impact of these variables on illness verification (Aderinto et al., 2023).

Although there have been improvements in diagnostic technologies, the causes of many ailments are still being actively studied. This requires ongoing efforts to enhance survival rates, especially for life-threatening conditions. Further work is required to explore the integration of diagnostic technologies and their influence on patient verification (Aderinto et al., 2023).

outcomes. The research utilizes three imaging technologies to assess the usefulness of these modalities in evaluating neurological issues, considering the different levels of severity reported in neurological illnesses and their growing popularity. The research posits that the findings of the study will provide neurological care providers with the necessary tools to get the most favorable diagnostic results in the first stages of clinical ambiguity. The primary aim of this study is to assess the precision of CT and MRI scans in the evaluation of neurological disorders. This research is expected to yield significant findings in the field of neuroimaging and assist healthcare practitioners in choosing the most suitable imaging modality for the precise and prompt diagnosis of neurological conditions.

a. Problem Statement

Neurological illnesses involve a diverse array of conditions affecting the brain, spinal cord, and peripheral nerves throughout the whole of the human body. The precise identification and efficient surveillance of these disorders are crucial for ascertaining suitable therapy strategies and forecasting patient results. CT and MRI play a pivotal role in the science of neuroimaging by offering detailed visual representations of the structures inside the brain and spinal cord. Nevertheless, every modality has distinct advantages and constraints that impact its efficacy in different clinical situations.

b. Research Gap

While both CT and MRI are integral to neuroimaging, there is a significant gap in comprehensive comparative analyses that address their efficacy and limitations across a broad spectrum of neurological disorders. Previous studies often focus on specific conditions or acute settings, leaving a gap in understanding their comparative effectiveness in diverse and long-term scenarios. This gap hinders the optimization of imaging strategies in clinical practice, necessitating a systematic comparison to guide medical professionals in choosing the appropriate modality based on the specific clinical requirements.

c. Hypothesis

It is hypothesized that MRI provides superior image quality and more detailed information compared to CT, making it more effective in diagnosing and monitoring chronic neurological conditions, whereas CT is more effective in emergencies where speed is crucial.

d. Research Objectives

• To systematically compare the efficacy of CT and MRI in diagnosing various neurological conditions.

• To identify specific scenarios where one modality may be preferred over the other based on factors such as speed, detail, patient safety, and cost.

• To evaluate the impact of these imaging modalities on the clinical outcomes of neurological patients.

LITERATURE REVIEW

A study conducted by Aljahdali et al., 2024 to determine the efficacy of radiological techniques in the diagnosis and characterization of brain disorders. The study aimed to assess the accuracy of CT and MRI in diagnosing neurological disorders. We conducted a retrospective analysis using CT or MRI scans to diagnose brain disorders, considering patient records with neurological issues regardless of symptom onset, severity, or final diagnosis. We excluded cases without a CT or MRI scan. A chi-square test was used to examine the association between variables, analyzing 3155 cases. The findings showed that the most common comorbidity was dyslipidemia, affecting 670 patients (21.6%), followed by hypertension in 548 patients (17.6%). Brain disorders were confirmed in 2426 (77%) patients, with strokes diagnosed in 1543 (48.9%). CT and MRI had an accuracy of 78% and 74%, respectively. There was no significant association (p>=0.05) between the scanning modalities, patient type, and gender in disease confirmation. The results indicate that both CT and MRI are over 75% accurate in detecting neurological disorders, with no significant difference between the two methods (Aljahdali et al., 2024).

A study by Aderinto et al., 2023 stated that cerebrovascular disease significantly impacts morbidity and mortality in Africa, where neuroimaging techniques have enhanced diagnosis and management. Despite this advancement, comprehensive reviews examining the effectiveness of neuroimaging in the African context are sparse. To address this gap, we reviewed literature from electronic databases including PubMed, Scopus, and Google Scholar, covering the period from 2000 to April 2023. We focused on peer-reviewed studies in English that discussed the use of neuroimaging for cerebrovascular disease in African populations, excluding non-peer-reviewed articles, letters, editorials, and unrelated studies. Initially, 102 articles were identified, but after removing duplicates and applying exclusion criteria, 51 articles remained for review. Our analysis highlights the critical role of neuroimaging technologies like CT, MRI, and skull X-rays in the diagnosis and management of cerebrovascular disease in Africa. CT scans are more accessible and less costly than MRI. However, significant barriers such as high equipment costs, a shortage of trained personnel, and inadequate infrastructure hinder the broader application of neuroimaging across the continent. Conclusively, while neuroimaging is vital for

managing cerebrovascular disease in Africa, overcoming these challenges is crucial to enhancing healthcare outcomes. Implementing policy recommendations to improve the availability and accessibility of neuroimaging services could significantly benefit public health in the region (Aderinto et al., 2023).

The study by Jindal et al., 2013 aimed to compare the CT and MRI findings in patients with eclampsia, focusing on their neurological signs and symptoms. In this prospective observational study, 25 eclampsia patients were examined, and their data were analyzed using Fisher's exact and chi-square tests. All participants presented with antepartum or intrapartum eclampsia and exhibited neurological features ranging from headaches and altered consciousness to coma. MRI revealed transient high T2 signal intensity in the cerebral cortex and subcortical white matter, indicative of edema. Additionally, MR angiography showed generalized vasospasm in 40% of the cases. MRI correlated more closely with the neurological presentations than CT, demonstrating 90% sensitivity and 100% specificity. The findings indicate that symptoms such as visual blurring and loss of vision, along with ophthalmological signs, suggest the involvement of the occipital lobe in eclampsia. MRI abnormalities in eclampsia patients correlate well with clinical findings and provide a more effective imaging modality than CT for evaluating this condition (Jindal et al., 2013).

R S & Kumar, 2013 stated that advances in medical imaging have introduced new multidimensional imaging modalities, significantly enhancing diagnostic radiology. CT and MRI are the two primary technologies capable of producing multidimensional images for radiological purposes. Typically, CT imaging of the brain is the initial radiologic examination used when a stroke is suspected. However, MRI offers high-resolution images with superior soft tissue characterization. This paper presents a comparative analysis of stroke diagnosis using CT and MRI images, employing digital image processing tools to identify infarcts and hemorrhages in the human brain. The process involves preprocessing medical images using median filtering, followed by segmentation with Gabor filtering and a seeded region growing algorithm. The technique is applied to CT and MRI brain images containing various types of infarcts, with the results evaluated visually. The findings suggest that the proposed method is

effective in detecting strokes and demonstrates that MRI is superior to CT in identifying stroke-related abnormalities (R S & Kumar, 2013).

METHOD AND MATERIAL

a. Research Design

This comparative cross-sectional will evaluate and compare the effectiveness of CT

and MRI in diagnosing and monitoring various neurological conditions. Data will be

collected at a single point in time from patients who have undergone both CT and MRI

scans for their respective conditions.

b. Study Setting

The study will be carried out at a hospital with tertiary care that is equipped with both

CT and MRI scanning capabilities. The major location for data collecting will be the

radiology department of the hospital, which will use its sophisticated imaging

equipment and patient records.

c. Study Duration

The research study is scheduled to extend a period of six months, commencing in

June 2024, and ending in November 2024. This time frame encompasses the duration

allocated for the gathering, analysis, and reporting of data.

d. Sample Size

According to a preliminary power estimate, the research will include a sample size of

200 patients to attain sufficient statistical power for detecting significant disparities

across the imaging modalities. The calculation of this sample size is based on a 95%

confidence level and an 80% power.

e. Sampling Technique

A purposive sample method will be used to choose participants. This approach will

guarantee the incorporation of individuals who have had both CT and MRI scans for

diverse neurological disease, kind of scan conducted, during the preceding year, so enabling

a direct juxtaposition of imaging outcomes.

f. Data Collection Tool

The collection of data will be conducted via a custom-designed data collecting form

including patient details, particular neurological disease, kind of scan conducted,

clinical results, and reports from radiologists. The use of this tool will facilitate the methodical collection of all pertinent data for the research.

g. Data Collection Procedure

Data will be gathered retrospectively from the medical records and radiological reports of patients. The data extraction process will be conducted by research assistants who have received proper training. To preserve confidentiality and mitigate prejudice, all gathered data will undergo anonymization.

h. Plan of Data Analysis

Descriptive statistics will be used in the process of data analysis to provide a concise summary of patient characteristics and imaging results. Chi-square tests will be used for comparative analysis of categorical data, while t-tests or ANOVA will be utilized for continuous variables, contingent upon the distribution of the data. P value less than 0.05 will be considered statistically significant. Moreover, IBM SPSS will be used for data analysis.

i. Ethical Consideration

The research will adhere to the ethical principles outlined in the Declaration of Helsinki and will undergo evaluation and approval by the hospital's Institutional Review Board (IRB). All participants will be required to provide informed consent after a comprehensive explanation of the study's objectives and methodologies. The confidentiality of all personal information will be maintained, and its use will be limited only to research objectives.

REFERENCES

Aderinto, N., Olatunji, D., Abdulbasit, M., & Edun, M. (2023). The essential role of neuroimaging in diagnosing and managing cerebrovascular disease in Africa: a review. Ann Med, 55(2), 2251490.

https://doi.org/10.1080/07853890.2023.2251490

Aljahdali, S., Azim, G., Zabani, W., Bafaraj, S., Alyami, J., & Abduljabbar, A. (2024). Effectiveness of radiology modalities in diagnosing and characterizing brain disorders. Neurosciences (Riyadh), 29(1), 37-43.

https://doi.org/10.17712/nsj.2024.1.20230048

Borsook, D. (2012). Neurological diseases and pain. Brain, 135(Pt 2), 320-344.

https://doi.org/10.1093/brain/awr271

De Luca, F., Kits, A., Martin Muñoz, D., Aspelin, Å., Kvist, O., Österman, Y., Diaz Ruiz, S., Skare, S., & Falk Delgado, A. (2024). Elective one-minute full brain multi-contrast MRI versus brain CT in pediatric patients: a prospective feasibility study. BMC Medical Imaging, 24(1), 23.

https://doi.org/10.1186/s12880-024-01196-6

Feigin, V. L., Vos, T., Nichols, E., Owolabi, M. O., Carroll, W. M., Dichgans, M., Deuschl, G., Parmar, P., Brainin, M., & Murray, C. (2020). The global burden of neurological disorders: translating evidence into policy. Lancet Neurol, 19(3), 255-265.

https://doi.org/10.1016/S1474-4422(19)30411-9

Hussain, S., Mubeen, I., Ullah, N., Shah, S., Khan, B. A., Zahoor, M., Ullah, R., Khan, F. A., & Sultan, M. A. (2022). Modern Diagnostic Imaging Techniques: Applications and Risk Factors in the Medical Field: A Review. Biomed Res Int, 2022, 5164970.

https://doi.org/10.1155/2022/5164970

Ilic, I., & Ilic, M. (2023). International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease. Heliyon, 9(7), e18222.

https://doi.org/10.1016/j.heliyon.2023.e18222

Jindal, M., Gaikwad, H., Hasija, B., & Vani, K. (2013). Comparison of neuroimaging by CT and MRI and correlation with neurological presentation in eclampsia.

International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2, 83. https://doi.org/10.5455/2320-1770.ijrcog20130215

R S, J., & Kumar, S. (2013). A comparative analysis of MRI and CT brain images for stroke diagnosis. https://doi.org/10.1109/AICERA-ICMiCR.2013.6575935